Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD

Chest

Volumn 127, Issue 3, 2005, Pages 809-817

  Casaburi, Richard ^a   Kukafka, David ^b   Cooper, Christopher B ^c   Witek Jr , Theodore J ^d   Kesten, Steven ^d  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b Northern Colorado Pulmonary Consultants PC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

COPD; Exercise; Pulmonary rehabilitation; Tiotropium

Indexed keywords

PLACEBO; SALBUTAMOL; TIOTROPIUM BROMIDE; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; SCOPOLAMINE DERIVATIVE; TIOTROPIUM;

ADULT; AEROSOL; AGE DISTRIBUTION; AGED; ANTICHOLINERGIC EFFECT; ARTICLE; ARTIFICIAL VENTILATION; BINDING SITE; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DYSPNEA; ENDURANCE; EXERCISE TOLERANCE; FEMALE; HEALTH STATUS; HUMAN; LUNG INFLATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PULMONARY REHABILITATION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY AIRFLOW; SAINT GEORGE RESPIRATORY QUESTIONNAIRE; SCORING SYSTEM; TRANSITION DYSPNEA INDEX; VELOCITY; WORK; EXERCISE TEST; FORCED EXPIRATORY VOLUME; INHALATIONAL DRUG ADMINISTRATION; KINESIOTHERAPY; MIDDLE AGED; PATHOPHYSIOLOGY; QUALITY OF LIFE; VITAL CAPACITY;

ADMINISTRATION, INHALATION; ADULT; AGED; AGED, 80 AND OVER; BRONCHODILATOR AGENTS; CHOLINERGIC ANTAGONISTS; DOUBLE-BLIND METHOD; DYSPNEA; EXERCISE TEST; EXERCISE THERAPY; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SCOPOLAMINE DERIVATIVES; VITAL CAPACITY;

EID: 15844429415     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.127.3.809     Document Type: Article

References (25)

1. British Thoracic Society. Pulmonary rehabilitation. Thorax 2001; 56:827-834
2. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based guidelines. ACCP/AACVPR Pulmonary Rehabilitation Guidelines Panel. Chest 1997; 112:1363-1396
3. American Thoracic Society. Pulmonary rehabilitation 1999. Am J Respir Crit Care Med 1999; 159:1666-1682
4. Liesker JWJ, Wijstra PJ, Ten Hacken NHT, et al. A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD. Chest 2002; 121:597-608
5. Saey D, Debigare R, LeBlanc P, et al. Contractile leg fatigue after cycle exercise. Am J Respir Crit Care Med 2003; 168:425-430
6. Casaburi R, Mahler DA, Jones PW, et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002; 19:217-224
7. Vincken W, van Noord JA, Greefhorst APM, et al. Improvement in health status in patients with COPD during one year treatment with tiotropium. Eur Respir J 2002; 19:209-216
8. Celli B, ZuWallack R, Wang S, et al. Improvements in resting inspiratory capacity and hyperinflation with tiotropium in COPD with increased static lung volumes. Chest 2003; 124:1743-1748
9. O'Donnell DE, Fluge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnea and exercise tolerance in COPD. Eur Respir J 2004; 23:832-840
10. O'Donnell DE, Webb KA. Exertional breathlessness in patients with chronic airflow limitation. Am Rev Respir Dis 1993; 148:1351-1357
11. O'Donnell DE, Lam M, Webb KA. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160:542-549
12. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1995; 152:877-5120
13. Morris JF, Koski A, Temple WP, et al. Fifteen year interval spirometric evaluation of the Oregon predictive equations. Chest 1988; 93:123-127
14. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152:1107-1136
15. Mahler DA, Weinberg DH, Wells CK, et al. Baseline dyspnea index and transitional dyspnea index: the measurement of dyspnea. Chest 1984; 85:751-758
16. Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of health status for chronic airflow limitation. Am Rev Respir Dis 1992; 145:1321-1327
17. Witek TJ Jr, Mahler DA. Minimal important difference of the transition dyspnoea index in a multinational clinical trial. Eur Respir J 2003; 21:267-272
18. Witek TJ Jr, Mahler DA. Meaningful effect size and patterns of response of the transition dyspnea index. J Clin Epidemiol 2003; 56:248-255
19. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003; 167:211-277
20. Brusasco V, Hodder R, Miravitlles M, et al. Health outcomes following SLX months treatment with once daily tiotropium compared to twice daily salmeterol in patients with COPD. Thorax 2003; 58:399-404
21. Green RH, Singh SJ, Williams J, et al. A randomized controlled trial of four weeks versus seven weeks of pulmonary rehabilitation in chronic obstructive pulmonary disease. Thorax 2001; 56:143-145
22. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: updated 2004. Available at: http://www.goldcopd. org. Accessed February 8, 2005
23. O'Donnell DE, McGuire MA, Samis L, et al. The impact of exercise reconditioning on breathlessness in severe chronic airflow limitation. Am J Respir Crit Care Med 1995; 152: 2005-2013
24. Foglio K, Bianchi L, Bruletti G, et al. Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction. Eur Respir J 1999; 13:125-132
25. Ramirez-Venegas A, Ward JL, Olmstead EM, et al. Effect of exercise training on dyspnea measures in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 1997; 17:103-109